Journal
GENES AND IMMUNITY
Volume 3, Issue 7, Pages 414-418Publisher
NATURE PUBLISHING GROUP
DOI: 10.1038/sj.gene.6363909
Keywords
interleukin-12; immune regulation; Th1-Th2; severe malaria
Categories
Funding
- NIAID NIH HHS [R01 AI41764] Funding Source: Medline
Ask authors/readers for more resources
Interleukin-12 (IL-12) is an important regulatory cytokine in infection and immunity. Administration of IL-12 may reduce complications of severe malaria in rodents. Polymorphisms in IL12B, the gene encoding the IL-12 p40 subunit, influence the secretion of IL-12 and susceptibility to Type 1 diabetes. We therefore investigated whether IL12B polymorphisms may affect the outcome of severe malaria. Homozygosity for a polymorphism in the IL12B promoter was associated with increased mortality in Tanzanian children having cerebral malaria but not in Kenyan children with severe malaria. Furthermore, homozygotes for the IL12B promotor polymorphism had decreased production of nitric oxide, which is in pad regulated by IL-12 activity. These studies suggest that IL12B polymorphisms, via regulation of IL-12 production, may influence the outcome of malaria infection in at least one African population.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available